Home

Bioworkshops sell "Eculizumab"

Basic Information

614
20
6
4.7(65)

Trade Type

Sell

Product Name

Eculizumab

Manufacturer(s)

Specifications

  • Expression System: Developed from a proprietary mammalian cell line supported by a Drug Master File (DMF) filing, enabling global regulatory submissions
  • Purity: Proven high degree of analytical comparability to the reference product (eculizumab, anti-C5 mAb, CAS 219685-50-4), supporting regulatory and clinical acceptance
  • Application: Complement C5 inhibitor monoclonal antibody (biosimilar), with a representative indication of paroxysmal nocturnal hemoglobinuria (PNH); originator approved in the United States in 2007

Documents

GMP
Filters:
Sort by:

    No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product